Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
The Journal of Allergy and Clinical Immunology
|
December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol
Edwin H Kim, Stacie M Jones, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology
|
March 9, 2018
Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy
M Cecilia Berin, Alexander Grishin, Madhan Masilamani, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial
David M Fleischer, A Wesley Burks, Brian P Vickery, et al.
Science (New York, N.Y.)
|
March 12, 2005
Complement factor H polymorphism in age-related macular degeneration
Robert J Klein, Caroline Zeiss, Emily Y Chew, et al.
Allergy
|
March 27, 2016
Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness
B L Wright, M Kulis, K A Orgel, et al.
The New England Journal of Medicine
|
July 20, 2012
Oral immunotherapy for treatment of egg allergy in children
A Wesley Burks, Stacie M Jones, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology
|
June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy
Edwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology
|
March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy
Stacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology
|
October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts
M Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology
|
December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research
Amy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
The Journal of Allergy and Clinical Immunology
|
December 28, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol
Edwin H Kim, Stacie M Jones, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology
|
March 9, 2018
Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy
M Cecilia Berin, Alexander Grishin, Madhan Masilamani, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial
David M Fleischer, A Wesley Burks, Brian P Vickery, et al.
Science (New York, N.Y.)
|
March 12, 2005
Complement factor H polymorphism in age-related macular degeneration
Robert J Klein, Caroline Zeiss, Emily Y Chew, et al.
Allergy
|
March 27, 2016
Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness
B L Wright, M Kulis, K A Orgel, et al.
The New England Journal of Medicine
|
July 20, 2012
Oral immunotherapy for treatment of egg allergy in children
A Wesley Burks, Stacie M Jones, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology
|
June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy
Edwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology
|
March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy
Stacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology
|
October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts
M Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology
|
December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research
Amy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
Page
of 13